Standard cost-effectiveness analysis (CEA) does not provide the information about distributional equity impacts that decision makers need to reduce unjust differences in health by socioeconomic status, ethnicity and other aspects of social disadvantage. Continue Reading
Performing and using cost-effectiveness analyses is a core activity for many of us working in HEOR. Many shortcomings of CEA are well known (it fails to account for budget impact, “real option value”, “the value of hope”, etc.), but CEA as currently performed has an even bigger problem than any of those: equity. Continue Reading
Written By: Americans spend more on prescription drugs than anyone else in the world. In a move to address this, CVS Caremark announced in August that it would allow self-funded insurers to exclude from their plan any drug launched at… Continue Reading
